Biotech’s ‘founding father’ and influential deal broker Fred Frank dies at 89

Frederick “Fred” Frank, legendary investment banker and biotech giant who reshaped the structure of the biopharma industry by brokering such influential deals as Roche’s initial purchase of Genentech stock in 1990, passed away over the weekend.

PureTech CEO Daphne Zohar first shared the news of Frank’s death on Twitter. He...

Click to view original post